Ancestry‐specific effects of APOE on AD endophenotypes and modifiable risk factors
Ana I Boeriu, Brian Fulton‐Howard, Nicole Phillips, Robert Barber, Sid E. O'Bryant, Kristine Yaffe, Shea J Andrews · 2025
Read Ancestry‐specific effects of APOE on AD endophenotypes and modifiable risk factors by Ana I Boeriu, Brian Fulton‐Howard, Nicole Phillips, Robert Barber, Sid E. O'Bryant, Kristine Yaffe, Shea J Andrews (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712325.txt.
Description
Ana I Boeriu and co-authors study how the APOE gene acts across ancestries in a 2025 report on Alzheimer's disease. The gene's e4 form is the strongest common genetic risk for the late-onset form, but its force seems to vary by ancestry. The team used data from 2,505 adults in a health disparities cohort: white, Hispanic, and African American participants.
The e4 form tracked lower body weight, worse thinking, thinner cortex, and marker shifts in blood. The e2 form cut the risk of lipid problems. Some effects differed by ancestry, most clearly for amyloid and tau blood markers. African ancestry participants showed lower amyloid ratios than the other groups. The authors say ancestry must be counted in gene research and care.
Catalog record
| CREATOR | Ana I Boeriu, Brian Fulton‐Howard, Nicole Phillips, Robert Barber, Sid E. O'Bryant, Kristine Yaffe, Shea J Andrews |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |